Pt. Sekar Bumi, Tbk.

7 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• COLOR LBLG1 refused line

  Artificial coloring not declared

  The product appeared to contain an artificial coloring without labeling that states that fact.

• UNSAFE COL1 refused line

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

• VETDRUGRES1 refused line

  Animal drug residue

  The product appeared to contain a new animal drug, or a conversion product of one, that is unsafe within the meaning of section 512 of the FD&C Act.

Questions about Pt. Sekar Bumi, Tbk.

Is Pt. Sekar Bumi, Tbk. on an FDA import alert?

Yes. As of October 26, 2026, Pt. Sekar Bumi, Tbk. is on the red list of FDA Import Alert 16-129, “Seafood products: nitrofurans”, for shrimp; FDA published the listing on August 19, 2026.

Has FDA refused shipments from Pt. Sekar Bumi, Tbk.?

Yes. FDA refused 2 shipment lines from Pt. Sekar Bumi, Tbk. between December 2, 2025 and February 11, 2026. The most recent, on February 11, 2026, was shrimp and prawns, aquaculture harvested fishery/seafood products, charged as VETDRUGRES (animal drug residue).

Why did FDA refuse Pt. Sekar Bumi, Tbk.'s shipments?

The most frequent charges are COLOR LBLG (artificial coloring not declared, 1 line) and UNSAFE COL (color additive unsafe under section 721, 1 line).

When was Pt. Sekar Bumi, Tbk. last inspected by FDA?

FDA's most recent inspection of Pt. Sekar Bumi, Tbk. with a final classification is dated February 14, 2012 and was classified NAI (No Action Indicated).

What is Pt. Sekar Bumi, Tbk.'s FEI number?

Pt. Sekar Bumi, Tbk.'s FDA Establishment Identifier (FEI) is 3004314312.

Can shipments from Pt. Sekar Bumi, Tbk. still enter the U.S.?

Shipments of shrimp from Pt. Sekar Bumi, Tbk. can be detained without physical examination under Import Alert 16-129; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).